Milestone Scientific, Inc.

MLSS Healthcare Medical Instruments & Supplies

Milestone Scientific, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $9.0 million, up 3.99% from fiscal 2024. In the quarter to June 2026, revenue grew 22.3%, EPS grew 50.0%, free cash flow grew 66.7% and total debt fell 43.0%, each against the same quarter a year earlier. Operating cash flow growth for three consecutive years.

0.33 0.00 0.00%
Market cap
$29.6M
P/E
0.0×
Fwd P/E
−10.4×
Dividend yield
—
F-score
2/9
Altman Z
−22.07
Beneish M
−3.99
Dividend safety
n/a
Jun '26 Mar '26 Dec '25 Sep '25 Older periods
P/E ratio
0.00 0.00 0.00 0.00

+8 more quarters

P/S ratio
3.16 2.77 2.47 4.15
P/FCF ratio
0.00 0.00 0.00 0.00
P/Operating CF
(50.93) 284.13 (98.00) 452.88
P/B ratio
8.59 10.79 7.88 14.53
EV/Sales
2.99 2.73 2.44 4.09
EV/EBITDA
0.00 0.00 0.00 0.00
EV/FCF
(32.98) (11.94) (6.99) (8.27)
Current Ratio
1.85 1.51 1.81 1.61
Net Debt/EBITDA
1.57 0.48 0.28 0.47
Debt/Equity
0.14 0.36 0.29 0.33
Earnings Yield
(13.75%) (18.62%) (23.70%) (18.67%)
Free Cash Flow Yield
(2.87%) (8.25%) (14.12%) (11.92%)
Free Cash Flow per Share
(0.01) 0.00 0.00 0.00
Book value per Share
0.04 0.03 0.03 0.03
Free Cash Flow
(0.59) 0.09 (0.23) 0.08
EV/EBIT
0.00 0.00 0.00 0.00
Other line items

Show all line items

Columns are period end dates